In the last 12 months, insiders at REVELATION BIOSCIENCES, INC. ($REVB) filed 21 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
REVELATION BIOSCIENCES, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Rolke James (Chief Executive Officer) — 4 transactions totaling $1,111,849
- Zygmont Chester Stanley III (Chief Financial Officer) — 4 transactions totaling $650,167
- Chawla Lakhmir S (Not found) — 4 transactions totaling $62,666
- CARVER JENNIFER (Not found) — 4 transactions totaling $61,589
- ROPER JESS (Not found) — 4 transactions totaling $61,427
View all SEC Filings for REVELATION BIOSCIENCES, INC. (REVB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Chawla Lakhmir S | Not found | F | Common Stock | 2261 | $1.85 | 12,158.0000 | 5,924,137 | 15.68% | 0.04% |
| Feb. 3, 2026 | ROPER JESS | Not found | F | Common Stock | 1591 | $1.85 | 12,828.0000 | 5,924,137 | 11.03% | 0.03% |
| Feb. 4, 2026 | Zygmont Chester Stanley III | Chief Financial Officer | F | Common Stock | 13100 | $1.65 | 105,350.0000 | 5,924,137 | 11.06% | 0.22% |
| Feb. 3, 2026 | Rolke James | Chief Executive Officer | F | Common Stock | 8521 | $1.86 | 224,853.0000 | 5,924,137 | 3.65% | 0.14% |
| Feb. 3, 2026 | CARVER JENNIFER | Not found | F | Common Stock | 1661 | $1.87 | 12,758.0000 | 5,924,137 | 11.52% | 0.03% |
| Jan. 8, 2026 | Chawla Lakhmir S | Not found | A | Common Stock | 41981 | $0.90 | 73,353.0000 | 5,924,137 | 133.82% | 0.71% |
| Jan. 8, 2026 | Rolke James | Chief Executive Officer | A | Common Stock | 532829 | $0.90 | 1,334,149.0000 | 5,924,137 | 66.49% | 8.99% |
| Jan. 8, 2026 | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 78145 | $0.90 | 869,435.0000 | 5,924,137 | 9.88% | 1.32% |
| Jan. 8, 2026 | CARVER JENNIFER | Not found | A | Common Stock | 41981 | $0.90 | 73,357.0000 | 5,924,137 | 133.80% | 0.71% |
| Jan. 8, 2026 | ROPER JESS | Not found | A | Common Stock | 41981 | $0.90 | 73,353.0000 | 5,924,137 | 133.82% | 0.71% |
| Oct. 29, 2025 | ROPER JESS | Not found | A | Common Stock | 15625 | $1.28 | 15,747.0000 | 905,228 | 9999.99% | 1.73% |
| Oct. 29, 2025 | Chawla Lakhmir S | Not found | A | Common Stock | 15625 | $1.28 | 15,747.0000 | 905,228 | 9999.99% | 1.73% |
| Oct. 29, 2025 | Rolke James | Chief Executive Officer | A | Common Stock | 390614 | $1.28 | 410,706.0000 | 905,228 | 1944.13% | 43.15% |
| Oct. 29, 2025 | CARVER JENNIFER | Not found | A | Common Stock | 15625 | $1.28 | 15,751.0000 | 905,228 | 9999.99% | 1.73% |
| Oct. 29, 2025 | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 390614 | $1.28 | 400,676.0000 | 905,228 | 3882.07% | 43.15% |
| Feb. 11, 2025 | Chawla Lakhmir S | Not found | A | Common Stock | 181 | $3.87 | 181.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | TIDMARSH GEORGE F | Not found | A | Common Stock | 181 | $3.87 | 355.0000 | 0 | 104.02% | 0.00% |
| Feb. 11, 2025 | Zygmont Chester Stanley III | Chief Financial Officer | A | Common Stock | 15048 | $3.87 | 15,117.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | Rolke James | Chief Executive Officer | A | Common Stock | 30095 | $3.87 | 30,179.0000 | 0 | 9999.99% | 0.00% |
| Feb. 11, 2025 | ROPER JESS | Not found | A | Common Stock | 181 | $3.87 | 185.0000 | 0 | 4525.00% | 0.00% |
| Feb. 11, 2025 | CARVER JENNIFER | Not found | A | Common Stock | 181 | $3.87 | 193.0000 | 0 | 1508.33% | 0.00% |